Dezhan HealthCare Co Ltd

SHE:000813 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.02 Billion
CN¥7.49 Billion CNY
Market Cap Rank
#9300 Global
#1891 in China
Share Price
CN¥3.57
Change (1 day)
-0.56%
52-Week Range
CN¥2.97 - CN¥4.85
All Time High
CN¥13.69
Categories
Companies in China Drug Manufacturers - Specialty & Generic Cannabis & CBD
About

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more

Dezhan HealthCare Co Ltd (000813) - Net Assets

Latest net assets as of September 2025: CN¥4.96 Billion CNY

Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has net assets worth CN¥4.96 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.23 Billion) and total liabilities (CN¥271.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.96 Billion
% of Total Assets 94.82%
Annual Growth Rate 10.53%
5-Year Change -13.24%
10-Year Change 276.22%
Growth Volatility 55.63

Dezhan HealthCare Co Ltd - Net Assets Trend (1995–2024)

This chart illustrates how Dezhan HealthCare Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Dezhan HealthCare Co Ltd (1995–2024)

The table below shows the annual net assets of Dezhan HealthCare Co Ltd from 1995 to 2024.

Year Net Assets Change
2024-12-31 CN¥5.16 Billion -1.46%
2023-12-31 CN¥5.24 Billion -0.81%
2022-12-31 CN¥5.28 Billion -3.40%
2021-12-31 CN¥5.47 Billion -8.11%
2020-12-31 CN¥5.95 Billion +6.08%
2019-12-31 CN¥5.61 Billion +6.25%
2018-12-31 CN¥5.28 Billion +16.19%
2017-12-31 CN¥4.55 Billion +21.16%
2016-12-31 CN¥3.75 Billion +173.26%
2015-12-31 CN¥1.37 Billion +1.55%
2014-12-31 CN¥1.35 Billion -4.12%
2013-12-31 CN¥1.41 Billion +239.60%
2012-12-31 CN¥415.20 Million -3.20%
2011-12-31 CN¥428.93 Million +0.86%
2010-12-31 CN¥425.26 Million +0.39%
2009-12-31 CN¥423.61 Million -11.50%
2008-12-31 CN¥478.64 Million +1.83%
2007-12-31 CN¥470.05 Million +4.25%
2006-12-31 CN¥450.91 Million +37.80%
2005-12-31 CN¥327.22 Million +10.50%
2004-12-31 CN¥296.13 Million -37.33%
2003-12-31 CN¥472.51 Million -30.18%
2002-12-31 CN¥676.78 Million +4.04%
2001-12-31 CN¥650.49 Million +0.06%
2000-12-31 CN¥650.09 Million +1.65%
1999-12-31 CN¥639.51 Million +4.35%
1998-12-31 CN¥612.87 Million +82.78%
1997-12-31 CN¥335.31 Million +14.56%
1996-12-31 CN¥292.70 Million +3.29%
1995-12-31 CN¥283.36 Million --

Equity Component Analysis

This analysis shows how different components contribute to Dezhan HealthCare Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 220617.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥3.91 Billion 75.87%
Common Stock CN¥869.08 Million 16.85%
Other Comprehensive Income CN¥18.23 Million 0.35%
Other Components CN¥357.14 Million 6.92%
Total Equity CN¥5.16 Billion 100.00%

Dezhan HealthCare Co Ltd Competitors by Market Cap

The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their market capitalization.

Company Market Cap
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
 		$614.30 Million
MORGAN ADVANCED MAT.LS-25
F:MGJ
 		$614.42 Million
Jubilant Pharmova Limited
NSE:JUBLPHARMA
 		$614.47 Million
Hatsun Agro Product Limited
NSE:HATSUN
 		$614.52 Million
Haian Rubber Grp Co Ltd
SHE:001233
 		$613.93 Million
Jiangxi Bestoo Energy Co Ltd
SHE:001376
 		$613.88 Million
Jyoti CNC Automation Limited
NSE:JYOTICNC
 		$613.77 Million
Ulker Biskuvi Sanayi AS
IS:ULKER
 		$613.76 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Dezhan HealthCare Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 5,237,902,679 to 5,158,023,472, a change of -79,879,207 (-1.5%).
  • Net loss of 20,413,063 reduced equity.
  • Dividend payments of 79,747 reduced retained earnings.
  • Share repurchases of 73,275,022 reduced equity.
  • Other comprehensive income increased equity by 20,284,403.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-20.41 Million -0.4%
Dividends Paid CN¥79.75K -0.0%
Share Repurchases CN¥73.28 Million -1.42%
Other Comprehensive Income CN¥20.28 Million +0.39%
Other Changes CN¥-6.40 Million -0.12%
Total Change CN¥- -1.53%

Book Value vs Market Value Analysis

This analysis compares Dezhan HealthCare Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.49x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 7.49x to 1.49x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1995-12-31 CN¥0.48 CN¥3.57 x
1996-12-31 CN¥0.49 CN¥3.57 x
1997-12-31 CN¥0.57 CN¥3.57 x
1998-12-31 CN¥1.04 CN¥3.57 x
1999-12-31 CN¥1.09 CN¥3.57 x
2000-12-31 CN¥1.11 CN¥3.57 x
2001-12-31 CN¥1.10 CN¥3.57 x
2002-12-31 CN¥1.11 CN¥3.57 x
2003-12-31 CN¥0.76 CN¥3.57 x
2004-12-31 CN¥0.47 CN¥3.57 x
2005-12-31 CN¥0.53 CN¥3.57 x
2006-12-31 CN¥0.70 CN¥3.57 x
2007-12-31 CN¥0.83 CN¥3.57 x
2008-12-31 CN¥0.78 CN¥3.57 x
2009-12-31 CN¥0.75 CN¥3.57 x
2010-12-31 CN¥0.87 CN¥3.57 x
2011-12-31 CN¥0.80 CN¥3.57 x
2012-12-31 CN¥0.57 CN¥3.57 x
2013-12-31 CN¥1.81 CN¥3.57 x
2014-12-31 CN¥1.64 CN¥3.57 x
2015-12-31 CN¥0.81 CN¥3.57 x
2016-12-31 CN¥1.67 CN¥3.57 x
2017-12-31 CN¥2.03 CN¥3.57 x
2018-12-31 CN¥2.36 CN¥3.57 x
2019-12-31 CN¥2.53 CN¥3.57 x
2020-12-31 CN¥2.66 CN¥3.57 x
2021-12-31 CN¥2.40 CN¥3.57 x
2022-12-31 CN¥2.38 CN¥3.57 x
2023-12-31 CN¥2.40 CN¥3.57 x
2024-12-31 CN¥2.40 CN¥3.57 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Dezhan HealthCare Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -0.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -4.38%
  • • Asset Turnover: 0.09x
  • • Equity Multiplier: 1.03x
  • Recent ROE (-0.40%) is below the historical average (2.70%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1995 14.28% 12.76% 0.33x 3.40x CN¥11.90 Million
1996 16.78% 13.11% 0.39x 3.32x CN¥19.53 Million
1997 15.11% 12.11% 0.38x 3.29x CN¥16.91 Million
1998 10.03% 13.03% 0.41x 1.86x CN¥197.41K
1999 10.77% 14.66% 0.41x 1.80x CN¥4.88 Million
2000 1.68% 2.38% 0.34x 2.10x CN¥-53.68 Million
2001 -22.52% -49.65% 0.24x 1.89x CN¥-209.39 Million
2002 0.85% 1.48% 0.30x 1.88x CN¥-59.43 Million
2003 -46.04% -53.90% 0.36x 2.38x CN¥-248.77 Million
2004 -65.51% -52.88% 0.47x 2.66x CN¥-206.41 Million
2005 3.19% 2.76% 0.60x 1.93x CN¥-21.08 Million
2006 2.87% 3.93% 0.55x 1.33x CN¥-30.95 Million
2007 3.75% 5.15% 0.56x 1.31x CN¥-28.17 Million
2008 0.48% 0.59% 0.69x 1.19x CN¥-43.26 Million
2009 -11.49% -18.74% 0.48x 1.27x CN¥-87.26 Million
2010 1.54% 2.13% 0.46x 1.55x CN¥-34.87 Million
2011 0.84% 1.16% 0.45x 1.61x CN¥-38.05 Million
2012 -2.36% -3.14% 0.51x 1.48x CN¥-49.65 Million
2013 2.31% 4.67% 0.30x 1.67x CN¥-87.47 Million
2014 33.58% 35.67% 0.49x 1.92x CN¥249.18 Million
2015 47.86% 43.18% 0.60x 1.85x CN¥402.81 Million
2016 17.63% 45.85% 0.37x 1.05x CN¥286.34 Million
2017 17.54% 35.90% 0.43x 1.13x CN¥342.64 Million
2018 17.62% 28.28% 0.56x 1.12x CN¥402.38 Million
2019 6.00% 18.98% 0.30x 1.06x CN¥-224.37 Million
2020 4.82% 29.55% 0.15x 1.09x CN¥-305.20 Million
2021 -1.07% -7.84% 0.13x 1.08x CN¥-594.79 Million
2022 -0.89% -8.22% 0.10x 1.07x CN¥-576.22 Million
2023 1.59% 16.73% 0.09x 1.03x CN¥-440.48 Million
2024 -0.40% -4.38% 0.09x 1.03x CN¥-536.22 Million

Industry Comparison

This section compares Dezhan HealthCare Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Dezhan HealthCare Co Ltd (000813) CN¥4.96 Billion 14.28% 0.05x $614.30 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million